For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Dementia - Independent medicine & health information for consumers & professionals Dementia
Show health professional infoLatest independent information about dementia, including medicines and non-drug treatments, written and reviewed by experts in Australia.
| Filter by audience: | |
|---|---|
| All | |
| Consumer | |
| Health professional | |
| Researchers & evaluators | |
| Members & stakeholders | |
| Other | |
| Title | Description | Type | Audience  |
Date* |
|---|---|---|---|---|
Antipsychotic medicines and dementia: a fine balancing act |
NPS is warning people about the use of antipsychotic medicines in people suffering behavioural or psychological problems associated with dementia. Studies show that using these medicines for longer than necessary, especially in the elderly, can lead to serious side effects that can be life-threatening |
Media release | Others | 2011-11-17 19:00:00 |
Antipsychotic monitoring tool |
Lists recommended monitoring intervals and what you need to check for in patients taking antipsychotic medicines long term. Print (2 pages) and add this the patient's notes. |
Professional publication - NPS News | Health Professionals | 2011-08-24 00:00:00 |
Clinical audit: Safe and effective use of antipsychotic therapy |
How are you managing your patients who require antipsychotics? Review 10 patients |
Professional activity - Clinical audit | Health Professionals | 2011-08-19 00:00:00 |
Drugs for Alzheimer’s disease: PBS criteria no longer include referral to a specialist |
The requirement for a specialist to confirm the diagnosis of Alzheimer’s disease for PBS subsidy of the cholinesterase inhibitors (donepezil, rivastigmine, galantamine) or memantine has changed. |
Professional publication - NPS RADAR - Brief item | Health Professionals | 2011-11-01 00:00:00 |
Erratum: Memantine (Ebixa) for dementia in moderately severe Alzheimer’s disease |
Correction of erroneous previously published dose for Memantine (Ebixa) |
Professional publication - NPS RADAR - Brief item | Health Professionals | 2008-12-01 00:00:00 |
Case study 54 report: Caring for patients with Alzheimer's disease |
Joseph, a 75-year-old retired engineer complained of memory loss several months ago and was referred to a psychogeriatrician |
Professional activity - Case study report | Health Professionals | 2008-11-01 00:00:00 |
Case study 54: Caring for patients with Alzheimer's disease |
Joseph, a 75-year-old retired engineer complained of memory loss several months ago and was referred to a psychogeriatrician |
Professional activity - Case study | Health Professionals | 2008-08-01 00:00:00 |
Case study 70: Antipsychotics |
Emily (28-years-old) was diagnosed with schizophrenia 9 months ago. She was prescribed an antipsychotic (risperidone) and in the last 6 months her dose has been stable. |
Professional activity - Case study | Health Professionals | 2011-08-01 00:00:00 |
Comparative information on antipsychotics |
Lists commonly used antipsychotics and incidences of common adverse effects |
Professional publication - NPS News | Health Professionals | 2011-08-24 00:00:00 |
Antipsychotics: programs and resources for carers and consumers |
Antipsychotic treatment-related websites and phonelines to support carers or consumers |
Professional tool - Prescribing software guide | Health Professionals | 2011-08-24 00:00:00 |
Antipsychotics for people with dementia and severe behavioural problems |
Latest independent information about Mental illness and antipsychotics and treatments written and reviewed by experts in Australia. |
Web page | Health Professionals,Consumers,Members & Stakeholders,Others,Research & Evaluation community | 2011-09-14 00:00:00 |
Articles on drugs for dementia & Alzheimer's Disease from NPS RADAR |
Get independent, evidence-based info on drugs for dementia & Alzheimer's Disease. Written for doctors, pharmacists & other health professionals. |
Topic overview | Health Professionals | 2009-10-28 00:00:00 |
Drugs of little use in treating dementia |
Investigation, diagnosis and treatment of dementia will increasingly be part of a GPs role as the number of new cases in Australia is forecast to reach 175,000 per year by 2050. |
Media release | Others | 2009-02-02 19:00:00 |
Drug use evaluation (DUE) of antipsychotic use for behavioural and psychological symptoms of dementia |
Sample pages of drug use evaluation (DUE) for use of antipsychotic medicines for managing behavioural and psychological symptoms of dementia in aged care homes. |
Professional activity - Drug Use Evaluation (DUE) for aged care facilities | Health Professionals | 2011-09-09 00:00:00 |
DUE of antipsychotic use in the management of dementia |
Information and login for the DUE for use of antipsychotic medicines for managing behavioural and psychological symptoms of dementia in aged care homes. |
Professional activity - Drug Use Evaluation (DUE) for aged care facilities | Health Professionals | 2008-04-15 00:00:00 |
Clinical audit: Safe and effective use of antipsychotic therapy |
How are you managing your patients who require antipsychotics? Review 10 patients |
Professional activity - Clinical audit | Health Professionals | 2011-08-19 00:00:00 |
Galantamine (Reminyl) prolonged-release capsules for dementia in Alzheimer's disease |
Reviews use of galantamine prolonged-release capsules for dementia in Alzheimer's disease, including comparison with immediate-release preparation and long-term therapeutic effect. |
Professional publication - NPS RADAR - Review | Health Professionals | 2004-12-01 00:00:00 |
GPs urged to routinely assess benefits and harms for patients taking antipsychotics |
Psychotic disorders affect 4% of Australians. Those taking antipsychotic medicines to treat their condition not only bear the burden of disease, but also a significant burden of side effects from the medicines they take. Balancing the benefits and harms of these medicines for each individual represents a constant challenge for GPs |
Media release | Others | 2011-09-07 19:00:00 |
Management of Behavioural and Psychological Symptoms of Dementia (BPSD): a Residential Aged Care facilities (RACF) nursing perspectives, Poster NMS 2010 |
Nursing perspectives on the management of Behavioural and Psychological Symptoms of Dementia (BPSD) at Residential Aged Care Facilities (RACF). Aristidi S, Loo T. National Medicine Symposium, 26-28 May 2010, Melbourne, Australia |
Event - Conference poster | Health Professionals,Research & Evaluation community | 2010-05-28 00:00:00 |
New Alzheimer's drugs |
Reviews evidence on efficacy of donepezil and rivastigmine in Alzheimer's disease, including side effects, and on managing behavioural disturbances in dementia using complementary medicine. Includes case study. |
Professional publication - NPS News | Health Professionals | 2001-06-01 00:00:00 |
Atypical antipsychotics |
Reviews atypical antipsychotics, including indications for use, adverse effects, and dosage recommendations. |
Professional publication - NPS News | Health Professionals | 2007-04-08 00:00:00 |
Dementia - Drug treatment |
Reviews non-drug treatments and drug treatments for dementia and Alzheimer’s disease, and when to consider stopping drug treatment. |
Professional publication - NPS News | Health Professionals | 2008-08-01 00:00:00 |
Antipsychotics - balancing benefits and harms |
This NPS News discusses ways to achieve the most favourable balance of clinical benefits and adverse effects for people with a psychotic illness or behavioural symptoms of dementia. |
Professional publication - NPS News | Health Professionals | 2011-08-01 00:00:00 |
Behavioural symptoms of dementia |
Information on managing behavioural and psychological symptoms of dementia including advice on non-drug strategies, the use of antipsychotics and the monitoring and followup care required. |
Professional publication - Prescribing Practice Review | Health Professionals | 2007-04-01 00:00:00 |
Symptoms of dementia |
Drugs used to treat dementia, including Alzheimer's disease, and when to stop treatment. Includes problems with anticholinergic drugs. |
Professional publication - Prescribing Practice Review | Health Professionals | 2008-09-01 00:00:00 |
Antipsychotic therapy - benefits and harms |
Reviews ways to achieve the best balance of clinical benefits and adverse effects for those with a psychotic illness or behavioural symptoms of dementia |
Professional publication - Prescribing Practice Review | Health Professionals | 2011-08-25 00:00:00 |
Risperidone (Risperdal) for behavioural disturbances in dementia |
Reviews use of risperidone for behavioural symptoms in dementia and discusses underlying factors and non-drug interventions. |
Professional publication - NPS RADAR - Review | Health Professionals | 2005-04-01 00:00:00 |
Treating dementia - drug therapy not the answer |
Almost 190,000 Australians have dementia and as Australia's population ages, dementia becomes a bigger challenge for doctors, their patients and carers. According to the National Prescribing Service Limited (NPS), who has found that there are limited benefits to using cholinesterase inhibitors and memantine in the treatment of patients with dementia drug therapy is not the answer. |
Media release | Others | 2008-10-09 00:00:00 |
Information on this website is published by NPS — an independent, evidence based, not-for-profit organisation funded by the Australian Government Department of Health and Ageing.
NPS develops its information under the guidance of experts in their field, editorial panels, expert reviewers and consumers. Find out more about how we develop our content.
Date published: 2010-12-17 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
